Analysts cranked up targets on beaten-down names today. TRIP Trip.com grabbed attention with 981% upside to consensus. The $32B travel giant fell 33% year to date creating massive gap between price and targets. RSI hit 27 showing extreme oversold conditions.
LI Li Auto commanded 753% upside potential from Wall Street. The $18B Chinese EV maker added 3% in 2026 despite sector pressure. Short interest climbed to 10 days to cover signaling heavy bear positioning. ORTEX short score reached 64 indicating elevated risk.
LEGN Legend Biotech saw targets implying 241% gains. The $3.1B cell therapy company dropped 23% this year while maintaining 86 total stock score. Short score hit 71 with bears controlling 3.6 days of float.
VKTX Viking Therapeutics held 184% upside with analysts backing the obesity drug developer. The $3.8B biotech posted 77 short score reflecting intense skepticism. Days to cover reached 9.7 suggesting entrenched positions.
TEAM Atlassian absorbed brutal 60% decline in 2026. Analysts maintained 159% upside conviction on the $17B software firm. RSI bottomed at 30 matching travel names in oversold territory.
Beaten sectors dominated extreme target premiums today.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
